Sera Prognostics, Inc.
SERA PROGNOSTICS REPORTS THIRD QUARTER 2026 FINANCIAL RESULTS
Company Drives Significant Increases in Test Volume and Ordering Providers with Florida Becoming Second Medicaid State Covering Test PreTRM® test…
Company newsroom
Sera Prognostics, Inc.
NASDAQ:SERA
2 releases
Sera Prognostics, Inc.
PreTRM® test volume increases 54% sequentially and approximately five-fold from 1Q26
Ordering healthcare providers increase 34% sequentially and approximately three-fold from 1Q26